Finance

Lists
QTTB:NASDAQ
Q32 Bio Inc
8,09 $
+1,25%
(+0,10) 1D
8,09 $
0,00% (0,00)
After hours
Closed: 8 қаз., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for QTTB...
Open
7,94 $
High
8,12 $
Low
7,62 $
Mkt. cap
240,83 млн
Avg. vol.
941,82 м.
Volume
729,54 м.
P/E ratio
2,71
52-wk high
23,57 $
52-wk low
1,90 $
EPS
2,99 $
Beta
0,31
Shares outstanding
29,77 млн
No. of employees
22
Open
7,94 $
High
8,12 $
Low
7,62 $
Mkt. cap
240,83 млн
Avg. vol.
941,82 м.
Volume
729,54 м.
P/E ratio
2,71
52-wk high
23,57 $
52-wk low
1,90 $
EPS
2,99 $
Beta
0,31
Shares outstanding
29,77 млн
No. of employees
22
News stories
From web sources and news partners
Stock Traders Daily
Stock Traders Daily
·
6 сағат бұрын
(QTTB) and the Role of Price-Sensitive Allocations
About Q32 Bio Inc
CEO-
Employees22
Founded2017
HeadquartersWaltham, Массачусетс, Америка Құрама Штаттары
Sector-
Websiteq32bio.com
Analyst ratings
Based on 7 analysts giving stock ratings to QTTB in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for QTTB in the last 3 months.
Highest
Current 8,09 $
59,00 $ (+629,30%)
Average
38,86 $ (+380,35%)
Lowest
29,00 $ (+258,47%)
Analyst
Recommendation
Action
Price target
Projected
Date
Maury Raycroft
Jefferies
Buy
Maintained
29,00 $
+258,5%
10/01/2026
Derek Archila
Wells Fargo
Buy
Reiterated
59,00 $
+629,3%
10/01/2026
Kaveri Pohlman
Clear Street
Buy
Initiated
38,00 $
+369,7%
10/01/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
36,00 $
+345%
09/30/2026
Judah Frommer
Morgan Stanley
Buy
Initiated
34,00 $
+320,3%
08/24/2026
Jay Olson
Oppenheimer
Buy
Maintained
40,00 $
+394,4%
08/06/2026
Joseph Catanzaro
Mizuho Securities
Buy
Reiterated
36,00 $
+345%
07/13/2026
Richard Poland
Wells Fargo
Hold
Maintained
10,00 $
+23,6%
05/28/2026
Unknown Analyst
Wells Fargo
Hold
Maintained
10,00 $
+23,6%
05/28/2026
Unknown Analyst
Cantor Fitzgerald
Buy
Initiated
-
-
05/18/2026
Imogen Mansfield
Cantor Fitzgerald
Buy
Initiated
-
-
05/18/2026
Imogen Mansfield
Cantor Fitzgerald
Buy
Initiated
-
-
05/18/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
53,74 млн
-
-
Cost of goods sold
3,56 млн
3,32 млн
3,22 млн
4,26 млн
Cost of revenue
3,56 млн
3,32 млн
3,22 млн
4,26 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,02 млн
4,54 млн
4,50 млн
4,86 млн
Operating expense
4,02 млн
4,54 млн
4,50 млн
4,86 млн
Total operating expenses
7,58 млн
7,86 млн
7,72 млн
9,12 млн
Operating income
-7,58 млн
45,88 млн
-7,72 млн
-9,12 млн
Other non operating income
-12,00 мың
-12,00 мың
-79,00 мың
73,00 мың
EBT including unusual items
-7,39 млн
57,73 млн
-7,61 млн
-8,95 млн
EBT excluding unusual items
-7,39 млн
46,07 млн
-7,61 млн
-8,80 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7,39 млн
57,73 млн
-7,61 млн
-8,95 млн
Net profit margin
-
107,43%
-
-
Earnings per share
-
-
-
-
Interest and investment income
500,00 м.
400,00 м.
392,00 м.
446,00 м.
Interest expense
-300,00 м.
-200,00 м.
-200,00 м.
-200,00 м.
Net interest expenses
200,00 м.
200,00 м.
192,00 м.
246,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
-7,49 млн
45,97 млн
-7,63 млн
-9,03 млн
Gain or loss from assets sale
-
-11,74 млн
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google қолданбалары